DE3545620A1 - Medicinal composition - Google Patents
Medicinal compositionInfo
- Publication number
- DE3545620A1 DE3545620A1 DE19853545620 DE3545620A DE3545620A1 DE 3545620 A1 DE3545620 A1 DE 3545620A1 DE 19853545620 DE19853545620 DE 19853545620 DE 3545620 A DE3545620 A DE 3545620A DE 3545620 A1 DE3545620 A1 DE 3545620A1
- Authority
- DE
- Germany
- Prior art keywords
- ash
- leaves
- functions
- medicinal composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 230000006870 function Effects 0.000 claims abstract description 6
- 244000181980 Fraxinus excelsior Species 0.000 claims abstract description 5
- 235000002918 Fraxinus excelsior Nutrition 0.000 claims abstract description 4
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 230000036642 wellbeing Effects 0.000 claims abstract description 4
- 230000000762 glandular Effects 0.000 claims abstract description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 230000007935 neutral effect Effects 0.000 claims description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 claims description 3
- 239000001472 potassium tartrate Substances 0.000 claims description 3
- 229940111695 potassium tartrate Drugs 0.000 claims description 3
- 235000011005 potassium tartrates Nutrition 0.000 claims description 3
- 229910021538 borax Inorganic materials 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 239000004328 sodium tetraborate Substances 0.000 claims description 2
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 229940124600 folk medicine Drugs 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000009291 secondary effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241001536358 Fraxinus Species 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000842783 Orna Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000021190 leftovers Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036421 sense of balance Effects 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- -1 stearate Ions Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Injection Moulding Of Plastics Or The Like (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
Die Erfindung betrifft eine neue medikamentöse Zusammen setzung, deren Gesamtaktivitäten mit dem Ausdruck psycho somatisch stabilisierend beschrieben werden kann.The invention relates to a new medicinal combination setting, whose overall activities are expressed with the expression psycho can be described somatically stabilizing.
Diese Zusammensetzung übt die folgenden Hauptaktivitäten aus:This composition practices the following main activities out:
- - Abweisungen von Überlastungen aller Arten, nämlich Dinre se, Intestinal-Funktionen, Funktionieren der Schweiß- und Talgdrüsen;- rejection of congestion of all kinds, namely Dinre se, intestinal functions, functioning of the sweat and Sebaceous glands;
- - Assimilation der Vitamine und Spurenelemente;- assimilation of vitamins and trace elements;
- - Übertragung krankhafter psychischer Zustände (Aggresivi tät, Depressivität) in normale Zustände ohne Sekundär- oder umgekehrte Wirkungen.- Transmission of pathological mental states (Aggresivi activity, depression) in normal states without secondary or reverse effects.
Diese komplexe Gesamtheit von Wirkungen übersetzt sich durch ein globales Gefühl des Gleichgewichts und des Wohl befindens, das zu erreichen kein einzelnes Medikament er möglicht. This complex set of effects translates through a global sense of balance and well-being to achieve that is not a single drug possible.
Dieses Ziel wird Dank des Vorhandenseins eines bestimmten Anteiles von Eschenblättern in pulverisiertem Zustand in dieser Zusammensetzung erreicht.This goal is achieved thanks to the presence of a specific one Proportion of powdered ash leaves in achieved this composition.
Die Esche, deren Blätter auf diese Art verwendet werden, ist vorzugsweise der Art Fraxinus Excelsior L., die sich in den Mittelmeerbereichen weit entwickelt, und die seit dem Altertum wegen ihrer vorteilhaften Eigenschaften anerkannt wurde, die in traditionellen Volksmedizinen eine weite An wendung gefunden haben. So wurden Absude von Eschenblättern als ein Jungbrunnengetränk für Arthritische und Gichtlei dende betrachtet.The ash, the leaves of which are used in this way, is preferably the species Fraxinus Excelsior L., which is in the Mediterranean areas, and since then Ancient times recognized for their beneficial properties has been widely used in traditional folk medicine have found application. So were decoctions of ash leaves as a fountain of youth for arthritic and gouty considered at the end.
Andere Arten von Esche können je nach Gegend verwendet wer den, beispielsweise Fraxinus Orna und die Manna-Esche.Other types of ash can be used depending on the area that, for example Fraxinus Orna and the manna ash.
Jedoch stellten derartige Absude nur wäßrige Auszüge dar, die nur einen Teil der nützlichen aktiven Bestandteile ent halten, nämlich den Teil, der in warmem Wasser löslich ist, während die anderen Bestandteile bis heute niemals ausge nutzt oder gar vollständig identifiziert wurden. Denn die bekannten Analysen, die das Vorhandensein verschiedener chemischer Zusammensetzungen in Eschenblättern betreffen, sind alle sehr alt und sehr vage. Nur einige Autoren des Endes des 19. Jahrhunderts haben in diesen Blättern neben derartigen Mineralien Zucker wie Inosit, Mannit, Dextrose und Querzitroside erkennen können, ebenso wie Apfelsäure, Gerbsäure-Gummis, Terpenöle, Diastasen und nicht identifi zierte organische Substanzen. Man kann daher davon ausge hen, daß nur die Zucker tatsächlich extrahiert wurden und den Absud darstellten, während die Gummis, Terpene und an dere organische Komponenten immer zusammen mit den Mineral resten weggeschüttet wurden.However, such decoctions were only watery extracts, which contains only a part of the useful active ingredients hold, namely the part that is soluble in warm water, while the other components have never gone out until today uses or have even been fully identified. Because the known analyzes that show the presence of different chemical compositions in ash leaves concern are all very old and very vague. Only a few authors of the End of the 19th century in addition to these sheets such minerals sugar as inositol, mannitol, dextrose and can recognize Querzitroside as well as malic acid, Tannic acid gums, terpene oils, diastases and not identifi graced organic substances. One can therefore assume that hen that only the sugars were actually extracted and the decoction represented, while the gums, terpenes and on their organic components always together with the mineral leftovers were thrown away.
Es sind diese organischen Komponenten, die den Zusammen setzungen nach der Erfindung ihre Originalität verleihen. It is these organic components that together lend the originality of the settings according to the invention.
Die Erfindung besteht daher darin, als hauptsächliches Wirkmittel in einer medikamentösen Zusammensetzung mit psy chomatisch stabilisierender Wirkung Eschenblätter der Va rietät Fraxinus Excelsior in pulverisiertem Zustand und ohne jede vorhergehende Reinigungs- oder Extraktions-Be handlung zu verwenden.The invention is therefore as main Active ingredients in a medicinal composition with psy chromatic stabilizing effect ash leaves from Va advises Fraxinus Excelsior in powdered state and without any previous cleaning or extraction action to use.
Die Zusammensetzungen nach der Erfindung enthalten im üb rigen eine bestimmte Anzahl Bestandteile mit Sekundärcha rakter, nämlich Metallsalze, insbesondere Natriumchlorid, neutrales Kaliumtartrat, Magnesiumstearat und Natriumbi carbonat, die in der stabilisierenden Wirkung der Zusam mensetzung durch Hinzufügung von Tartrat- und Stearat-An ionen zu dem Wirkungsmechanismus nützlich sind.The compositions according to the invention contain a certain number of components with secondary cha character, namely metal salts, especially sodium chloride, neutral potassium tartrate, magnesium stearate and sodium bi carbonate, which in the stabilizing effect of the together setting by adding tartrate and stearate Ions are useful in the mechanism of action.
Nach einem bevorzugten Ausführungsbeispiel können die Kom positionen nach der Erfindung enthalten:According to a preferred embodiment, the com positions according to the invention include:
pulverisierte Blätter von Fraxinus Excelsior L.2,5-3,5% Magnesiumchlorid3,0-4,0% neutrales Kaliumtartrat3,0-4,0% Magnesiumstearat2,0-3,0% neutrales Arzneimittelborax15,0-20,0% NatriumbicarbonatRest auf 100%powdered leaves of Fraxinus Excelsior L.2.5-3.5% Magnesium chloride 3.0-4.0% neutral potassium tartrate 3.0-4.0% Magnesium stearate 2.0-3.0% neutral drug borax 15.0-20.0% Sodium bicarbonate residue to 100%
Derartige Zusammensetzungen, die in Form von Tabletten ver abreicht werden, üben auf den Organismus die obengenannten wohltuenden Wirkungen aus, indem sie gleichzeitig bei dem Patienten eine deutliche Verbesserung des Zustandes durch Verschwinden von Streßzuständen bestimmen, die sich je nach Patient durch eine pathologische Depression oder Aggressi vität bemerkbar machen. Dieses Verschwinden wird weder von ungewünschten Sekundäreffekten noch von einer Umkehrung der Symptome begleitet, wie es ein häufiger Nachteil bei den Medikamenten dieser Art ist. Such compositions, the ver in the form of tablets are given, exercise the above on the organism beneficial effects by simultaneously with the Patients a significant improvement in the condition Determine the disappearance of stress conditions, which vary depending on Patient due to a pathological depression or aggression make vity noticeable. This disappearance is not caused by unwanted secondary effects still from reversing the Accompanied by symptoms, as is a common disadvantage among those Medication of this type is.
Man kann im übrigen mit einer bestimmten Wahrscheinlichkeit diese, unter wissenschaftlicher ärztlicher Kontrolle erhal tenen Resultate den positiven legendären Eigenschaften an nähern, die der Esche in der antiken, insbesondere griechi schen Mythologie zugeschrieben wurden.You can, moreover, with a certain probability receive this under scientific medical supervision the positive legendary properties approach that of ash in ancient times, especially greek mythology.
Die Indikationen der erfindungsgemäßen Zusammensetzung ha ben daher eine doppelte und komplementäre Natur:The indications of the composition according to the invention ha therefore have a double and complementary nature:
Einerseits für die Behandlungen, die die Zurückweisung von Überlastungen zum Ziel haben, durch Verbesserung der na türlichen Funktionen, unter ihnen alle Drüsenfunktionen, und durch die Verbesserung und Assimilierung der Vitamine und Spurenelemente.On the one hand for the treatments that the rejection of Targeting congestion by improving na natural functions, including all glandular functions, and by improving and assimilating the vitamins and trace elements.
Andererseits für die Behandlungen der Übertragung von krankhaften psychischen Zuständen des Typs der Aggressivi tät und Depressivität zur Schaffung eines allgemeinen Ge fühls des Gleichgewichts und des Wohlbefindens bei dem Pa tienten.On the other hand, for the treatments of transferring pathological psychological states of the type of aggressivi activity and depression to create a general ge feeling of balance and well-being with the pa served.
Es ist objektiv zu beachten, daß die Behandlung mit diesen Zusammensetzungen bei bestimmten Patienten temporäre Er scheinungen stark riechender Sekretionen zu Folge haben kann (Schweiß, Urin), oder gar von Fettschlacken in Form von Pickeln im Gesicht oder auf dem Rücken. Diese Sekre tionen werden mit Leichtigkeit beispielsweise durch ein Brennesselwurzelbad beseitigt.It is objective to note that treatment with these Compositions in certain patients temporary Er have the appearance of strongly smelling secretions can (sweat, urine), or even fat slag in the form from pimples on the face or on the back. That secret ions are easily with, for example, a Nettle root bath removed.
Obwohl diese Phänomene ziemlich störend sind, illustrieren sie jedoch den sehr starken Aktivitätsgrad der Zusammen setzungen nach der Erfindung und, da der aus Esche extra hierte Jungbrunnentee der Volksmedizin diese Phänomene nicht auslöste, illustrieren sie in gleicher Weise den Un terschied der Art, der Wirkung und der Ergebnisse dieser Zusammensetzung nach der Erfindung gegenüber diesem Ver jüngungstee. Although these phenomena are quite disturbing, illustrate however, the very strong level of activity of the together settlements according to the invention and, because of the extra ash folk medicine fountain of youth recognized these phenomena not triggered, they illustrate the Un in the same way Differentiated the type, the effect and the results of these Composition according to the invention compared to this ver young tea.
Man kann diesen Zusammensetzungen pharmazeutische Zucker hinzufügen, beispielsweise Lactose, Glykokoll und Analoge, ebenso wie neutrale pulverförmige Parfüms, insbesondere von gefriergetrockneten Früchten.Pharmaceutical sugar can be added to these compositions add, such as lactose, glycocoll and analogs, as well as neutral powdered perfumes, especially from freeze-dried fruit.
Diese Zusammensetzungen können so mit den Lebensmittel- Ergänzungen verglichen werden, wie sie bei der Naturheil kunde und der Naturtherapie verwendet werden.These compositions can thus be combined with the food Supplements are compared as they are with natural healing customer and natural therapy.
Claims (3)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8517119A FR2590171B1 (en) | 1985-11-18 | 1985-11-18 | FOOD SUPPLEMENT COMPOSITION FOR NATUROTHERAPY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3545620A1 true DE3545620A1 (en) | 1987-05-21 |
Family
ID=9324977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19853545620 Withdrawn DE3545620A1 (en) | 1985-11-18 | 1985-12-21 | Medicinal composition |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE903736A (en) |
| CA (1) | CA1271424A (en) |
| CH (1) | CH667011A5 (en) |
| DE (1) | DE3545620A1 (en) |
| FR (1) | FR2590171B1 (en) |
| GR (1) | GR852917B (en) |
| IT (1) | IT1191985B (en) |
| LU (1) | LU86184A1 (en) |
| NL (1) | NL8602784A (en) |
| PT (1) | PT81631B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008065457A2 (en) * | 2006-11-29 | 2008-06-05 | Ante Juros | Herbal mixture with fraxinus, achillea and melissa to improve metabolism, boost immunity and help in therapy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2059972A1 (en) * | 1969-08-11 | 1971-06-11 | Nicolas Roland | Antirheumatic, antideafness extract of ashes of the ash-tree |
-
1985
- 1985-11-18 FR FR8517119A patent/FR2590171B1/en not_active Expired
- 1985-11-27 LU LU86184A patent/LU86184A1/en unknown
- 1985-11-29 BE BE2/60857A patent/BE903736A/en not_active IP Right Cessation
- 1985-12-04 GR GR852917A patent/GR852917B/el unknown
- 1985-12-09 PT PT81631A patent/PT81631B/en not_active IP Right Cessation
- 1985-12-21 DE DE19853545620 patent/DE3545620A1/en not_active Withdrawn
-
1986
- 1986-01-08 IT IT67010/86A patent/IT1191985B/en active
- 1986-01-14 CH CH116/86A patent/CH667011A5/en not_active IP Right Cessation
- 1986-02-07 CA CA000501418A patent/CA1271424A/en not_active Expired - Lifetime
- 1986-11-04 NL NL8602784A patent/NL8602784A/en not_active Application Discontinuation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008065457A2 (en) * | 2006-11-29 | 2008-06-05 | Ante Juros | Herbal mixture with fraxinus, achillea and melissa to improve metabolism, boost immunity and help in therapy |
| WO2008065457A3 (en) * | 2006-11-29 | 2009-06-18 | Ante Juros | Herbal mixture with fraxinus, achillea and melissa to improve metabolism, boost immunity and help in therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| GR852917B (en) | 1986-04-07 |
| LU86184A1 (en) | 1986-03-24 |
| PT81631B (en) | 1988-04-21 |
| IT8667010A0 (en) | 1986-01-08 |
| FR2590171A1 (en) | 1987-05-22 |
| IT1191985B (en) | 1988-03-31 |
| BE903736A (en) | 1986-03-14 |
| NL8602784A (en) | 1987-06-16 |
| FR2590171B1 (en) | 1988-02-12 |
| CA1271424A (en) | 1990-07-10 |
| CH667011A5 (en) | 1988-09-15 |
| PT81631A (en) | 1986-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69830049T2 (en) | ESSENTIAL OIL CONDITIONING PREPARATION | |
| DE3705151C2 (en) | ||
| DE3435040A1 (en) | PHARMACEUTICAL COMPOSITION SUITABLE FOR TREATING HANG OVER SYMPTOMS | |
| DE102006056454A1 (en) | Taste-free, granular nutritional supplement, useful e.g. for preventing osteoporosis and psoriasis, contains synergistic combination of Spirulina, Chlorella and Lithothamnium algae | |
| DE60009145T2 (en) | COMPOSITION OF GINSENG AND GINKGO TO IMPROVE COGNITIVE ASSETS | |
| DE4413839C1 (en) | Prepn. to protect human bodies from oxidative processes | |
| Cheney | Aloe drug in human therapy | |
| DE3545620A1 (en) | Medicinal composition | |
| DE3225056C2 (en) | Use of the crushed fenugreek seeds (Trigonella foenum-graecum) as an active ingredient to combat toxic liver damage and / or to improve liver function | |
| DE3627010A1 (en) | PHARMACEUTICAL FOR THERAPY OF POOR ABSORPTION OF FOODSTUFFS AND (OTHER) ORALS TO BE TAKEN | |
| DE102005046892A1 (en) | Composition, useful for the treatment of e.g. oliguria, comprises plant extracts of Alismatis Orientale, Plantago asiatica or Plantago depressa and Polygonum multiflorum | |
| EP0384308B1 (en) | Extract medicament | |
| DE19633446B4 (en) | Medicinal products with lipid-lowering action | |
| DE102004052882A1 (en) | Liquid food auxiliary agent, to e.g. stabilize immune system, comprises fruit concentrates (e.g. concentrates of red grape, apple, rose hip, peach and red currant), ascorbic acid, dextrose-monohydrate; maleic acid; and nitrogen | |
| DE202007002146U1 (en) | Herbal composition, useful to treat, e.g. cancer, comprises extracts of Ginseng flowers and roots, Astragalus, Atractylodes, Angelica, Citrus reticulata, Bupleurum chinenis, sweet woodrose and Cimicifuga root | |
| WO1989006966A1 (en) | Herbal tea composition and process for producing it | |
| LU501504B1 (en) | POWDERED FOOD SUPPLEMENT FOR MAKING A BEVERAGE | |
| DE3809427A1 (en) | Use of seeds of the neem tree for the prophylaxis and therapy of viral infections | |
| AT105093B (en) | Process for the production of easily absorbable, internally applicable drugs from substances which are difficult to absorb per se. | |
| DE2523394A1 (en) | PHARMACEUTICAL PREPARATION | |
| Braun | Olive-leaf Extract Olea europaea | |
| DE10065832A1 (en) | Inexpensive, side-effect free weight reducing composition, comprising mixture of essential oils from mint, balm mint and fennel plants in e.g. alcoholic solution | |
| DE202006019784U1 (en) | Tea mixture, useful to treat e.g. bronchitis, comprises dried plant parts such as stalks, roots, leaves and/or blooms, raspberry, plantain, thyme, birch, dead nettle, stinging nettle and marshmallow | |
| DE3638290A1 (en) | Pharmaceutical composition | |
| FR2584929A1 (en) | Nutritional supplement composition based on Fraxinus excelsior leaves for nature-cure therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8141 | Disposal/no request for examination |